Baseline Predictors of Poor Outcome in Patients Too Good to Treat With Intravenous Thrombolysis [Clinical Sciences]

Conclusions—Approximately one third of patients deemed too good for intravenous tissue-type plasminogen activator are unable to be discharged directly to home. Given the current safety profile of intravenous tissue-type plasminogen activator, our results suggest that the concept of being too good to treat should be re-examined with an emphasis on the features associated with poor outcome identified in our study. If replicated, these findings could be incorporated into tissue-type plasminogen activator decision-making algorithms.
Source: Stroke - Category: Neurology Authors: Tags: Ischemic Stroke, Transient Ischemic Attack (TIA), Embolism, Thrombosis Original Contributions Source Type: research